Skip to main content
Menu
Language
Appearance

Why Diagnostic Reagents Get Stuck at Customs, and How Programs Get Them Through

ByIHJ Editorial BoardAugust 16, 20266 min read
WhatsAppEmail

A field program can spend months validating a rapid diagnostic test, negotiate a favorable price, and place the order, only to watch the shipment sit at a border crossing while the campaign it was meant to supply loses its window. For diagnostic sourcing and procurement teams, the manufacturing and quality-assurance steps are often the easiest part. The customs and import stage is where timelines actually break, and it is the stage least visible to the clinicians and program managers waiting for the kits.

Understanding why shipments stall, and which mechanisms field programs actually use to move them faster, matters as much as picking the right test kit in the first place.

What Actually Delays a Shipment at the Border

Delays at customs rarely come from a single cause. In practice, several recurring problems combine to hold up diagnostic shipments in low-resource settings:

  • Incomplete or inconsistent documentation. Mismatched product descriptions, incorrect quantities, or missing import permits are among the most common reasons a shipment gets flagged for manual review rather than cleared on sight.
  • Regulatory and tariff classification issues. Import regulations for diagnostics vary by country and change often. A reagent misclassified under the wrong tariff code, or a shipment missing a required national health registration, can trigger a hold pending clarification.
  • Duties, taxes, and payment processing. Even when a program qualifies for duty-free treatment, the paperwork proving that status still has to be assembled and verified before goods move.
  • Manual, paper-based customs processes. In many countries, clearance authority is concentrated in a small number of officials, and the absence of digital submission systems means a single missing signature can stall a shipment for days.
  • Port congestion and limited inspection capacity. A surge in shipments, whether from an outbreak response or a routine campaign cycle, can overwhelm the staff available to process them.
  • Border closures and export restrictions. Political instability or a producing country’s own export controls on medical goods can force a shipment to reroute, adding weeks.

None of these are exotic risks. They are the ordinary friction of moving a temperature-sensitive, regulated product across a border that was not built with diagnostics in mind.

Framework Agreements: Buying Power Set Up Before the Shipment Ever Leaves

The single biggest lever field programs have is arranging the terms of import before an order is placed, not after. Large pooled procurement mechanisms negotiate long-term agreements with manufacturers and freight forwarders that bundle end-to-end logistics, including customs clearance and in-country distribution, into a single pre-agreed process. UNICEF Supply Division’s long-term agreements with global freight forwarders work this way, and the Global Fund relies on procurement service agents to manage the same upstream supply chain functions on behalf of the programs it finances. More recently, the African Pooled Procurement Mechanism, coordinated through the Africa Centres for Disease Control and Prevention, has extended this model regionally, aiming to give national programs the purchasing power and customs predictability that come from ordering as part of a larger, standing agreement rather than a one-off shipment.

For a smaller program that cannot negotiate its own framework agreement, the practical takeaway is to buy through a channel that already has one, rather than sourcing independently and hoping customs cooperates.

Pre-Shipment Inspection: Catching Problems Before the Border Does

Pre-shipment inspection adds a verification step before goods leave the exporting country, checking that what is loaded actually matches what was ordered and that quality specifications are met. For in-vitro diagnostics recommended through the WHO’s Expert Review Panel for Diagnostics pathway, this kind of randomized sampling and testing before dispatch is part of how confidence in the product is established ahead of arrival. Independent inspection firms carry out this work on behalf of buyers across many categories of global trade, and the same logic applies to diagnostics: a problem caught at the factory gate is a phone call, while the same problem caught at the border is a delayed shipment and a program with no test kits.

Duty-Free Status and Import Waivers

Where they can be arranged, duty and tax exemptions remove one whole category of delay, though they do not remove the paperwork. UNICEF-procured supplies typically move under duty-free status, but the documentation proving eligibility still has to be prepared and checked at the border, which is why duty-free is a head start rather than an automatic pass. During acute crises, some donor governments have gone further: the temporary waivers of standard sourcing rules issued by USAID during the COVID-19 response are a documented example of a funder relaxing its own procurement conditions specifically to speed the flow of essential medical supplies when timelines could not absorb the usual review.

What a Procurement Team Can Actually Control

Framework agreements and waivers are structural advantages that individual programs often cannot create on their own. What every procurement team can control is smaller but still consequential:

LeverWhat it doesWho typically arranges it
Framework agreementsPre-negotiates logistics and customs handling before orderingPooled mechanisms (UNICEF, Global Fund, Africa CDC)
Pre-shipment inspectionVerifies product and paperwork before departureIndependent inspection firms, WHO-linked review pathways
Duty-free / waiver statusRemoves tax and tariff review, not documentationDonor agencies, UN procurement channels
In-country customs brokerManages classification and clearance locallyIndividual program or implementing partner

Working with a customs broker who specializes in healthcare logistics and knows the specific regulatory quirks of a given country is one of the few moves available to a program buying outside a large pooled channel. So is getting documentation right the first time: consistent product descriptions, accurate quantities, and complete permits are unglamorous, but they are also the single most cited reason shipments clear without incident.

Building the Import Timeline Into the Procurement Plan

The practical lesson for diagnostic sourcing and procurement is that customs clearance is not a logistics afterthought to be handled once the purchase order is signed. It is a procurement decision in its own right. Choosing a supplier reachable through an existing framework agreement, confirming pre-shipment inspection is built into the contract, and understanding whether a shipment qualifies for duty-free treatment are all questions worth answering before an order is placed, not while a campaign’s launch date is already at risk. The programs that consistently get validated test kits into the field on schedule tend to be the ones that treated the border as part of the procurement plan from the start.